Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.45 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.45 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | PYGB | P11216 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4635137 | 1.00 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| SCHEMBL5706329 | 1.00 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| SCHEMBL6435260 | 0.82 | LMNA (0.38) | — | |
| SCHEMBL25292780 | 0.81 | LGALS1 (0.40) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| SCHEMBL2490550 | 0.81 | LGALS1 (0.40) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| SCHEMBL2493091 | 0.81 | LGALS1 (0.40) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| B-D-Galactose SCHEMBL27599841 | 0.81 | LGALS1 (0.47) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| B-D-Galactose SCHEMBL8994742 | 0.81 | LGALS1 (0.47) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| D-Galactose SCHEMBL28145478 | 0.81 | LGALS1 (0.47) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| SCHEMBL25291631 | 0.80 | LGALS1 (0.39) | LGALS1LGALS3LGALS9LGALS8PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7049300-B2 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | L'OREAL (FR) | 2006-05-23 | — | — | US | claimed |
| US-20040048785-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | SOCIETE L'OREAL S.A. (FR) | 2004-03-11 | — | — | US | claimed |
| EP-1345919-A2 | NOVEL C-GLYCOSIDE DERIVATIVES AND USE THEREOF | L'OREAL (FR) | 2003-09-24 | — | — | EP | claimed |
| WO-2002051828-A2 | NOVEL C-GLYCOSIDE DERIVATIVES AND USE THEREOF | L'OREAL (FR) | 2002-07-04 | — | — | WO | claimed |
| EP-1345919-B1 | NOVEL C-GLYCOSIDE DERIVATIVES AND USE THEREOF | OREAL (FR) | 2013-05-22 | — | — | EP | disclosed |
| US-7732414-B2 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | L'OREAL S.A. (FR) | 2010-06-08 | — | — | US | disclosed |
| US-20060223763-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | L'OREAL S.A. (FR) | 2006-10-05 | — | — | US | disclosed |
| US-7049300-B2 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | L'OREAL (FR) | 2006-05-23 | — | — | US | disclosed |
| US-20040048785-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | SOCIETE L'OREAL S.A. (FR) | 2004-03-11 | — | — | US | disclosed |
| EP-1345919-A2 | NOVEL C-GLYCOSIDE DERIVATIVES AND USE THEREOF | L'OREAL (FR) | 2003-09-24 | — | — | EP | disclosed |
| WO-2002051828-A2 | NOVEL C-GLYCOSIDE DERIVATIVES AND USE THEREOF | L'OREAL (FR) | 2002-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223763-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | CSGALNACT1, FUT6, AREG | LGALS1 182/4885LGALS3 124/4885LGALS9 239/4885 |
| US-20040048785-A1 | C-glycoside compounds for stimulating the synthesis of glycosaminoglycans | CSGALNACT1, FUT6, AREG | LGALS1 182/4885LGALS3 124/4885LGALS9 239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.